Efforts to improve child neurodevelopment are critical to health, equity, and sustainable development, particularly in low-resource settings in the United States and globally. The colliding epidemics of food insecurity, infectious diseases, and noncommunicable diseases interact and impact neurodevelopment. Understanding the complex relationships between nutrition, inflammation, and neurodevelopment can inform clinical and public health interventions to improve outcomes. This article reviews key definitions, tools, and considerations for the assessment of nutrition, inflammation, and child neurodevelopment. The effectiveness of existing assessment tools to reflect status and biology, particularly in relation to each other, and to predict long-term changes in health is examined. The aim of this review is to present the extant evidence, identify critical research gaps, and suggest a research agenda for future longitudinal and intervention studies to address the assessment of nutrition, inflammation, and child neurodevelopment, particularly in lowresource settings. Despite research gaps, there is a strong relationship between nutrition, inflammation, environmental factors, and child neurodevelopment, which emphasizes the need to evaluate targeted, early interventions to improve long-term health and well-being. abstract by guest on June 2, 2017 Downloaded from
Recent research in a number of fields is shedding light on the complex interrelationships and influence of nutrition and inflammation, among other factors, on child neurodevelopment and long-term health outcomes. Although the etiologies of impaired neurodevelopment are complex, there is growing evidence for the independent and interrelated roles of malnutrition and inflammation on neurodevelopmental delay. 1 -3 In addition, important modifiers (ie, both protective and risk factors) of the relationship between nutrition, inflammation, and neurodevelopment need to be considered, including exposure to psychosocial influences and poverty and environmental risk factors, among others. 4, 5 Although the relationships between neurodevelopment, nutrition, and inflammation are reciprocal (eg, malnutrition can cause neurodevelopmental delay, but a child with neurodevelopmental delay is also at increased risk of malnutrition), we will focus on neurodevelopment as the outcome of ultimate clinical relevance.
To understand the complex relationship between child neurodevelopment and its modifying factors, accurate and relevant assessment tools are needed that are of use both clinically and programmatically. At the onset, a key challenge is to determine whether there is a gold standard for neurodevelopment and nutritional and inflammatory status because there are no established universal norms across the life course. This article is not intended to be a systematic review of the literature, but instead will: (1) provide an overview of key definitions, tools, and applications relevant to the assessment of child neurodevelopment, nutrition, and inflammation; and (2) identify critical research gaps and priorities. This article will also build on recently conducted work by the authors, including: the NICHD Biomarkers of Nutrition for Development (BOND) 6 and Inflammation and Nutrition Science for Programs and Interpretation of Research Evidence (INSPIRE) 7 projects, which have been charged with developing guidance on biomarkers of exposure, status, and function for micronutrients and inflammation 6 -8 ; and the Interactions of Malnutrition and Enteric Infections: Consequences for Child Health and Development (MAL-ED) study, which is evaluating the relationships between enteric pathogens, malnutrition, gut physiology, and cognitive development. 9 Furthermore, this review will focus on assessment in culturally diverse, resource-limited settings around the globe, where the burden of malnutrition and inflammation is the highest.
The vernacular with regard to neurodevelopment, nutrition, and inflammation is complex, so, for the purposes of this article and the others in this supplement, we summarize key definitions and terminology in Table 1 . Of note, there is not a clear consensus definition in the literature for several of these terms, because definitions are often based on the perspective of researchers in their respective fields of study. Because this article is meant to be multi-and transdisciplinary, we have attempted to present an inclusive definition of key terminology when possible.
In this article, we define neurodevelopment as the dynamic interrelationship between environment, genes, and brain whereby the brain develops across time to establish sensory, motor, cognitive, socioemotional, cultural, and behavioral adaptive functions. This definition has been modified for this effort from an earlier version recently published in Nature. 12 Nutrition is defined as the science of food, the nutrients and other substances therein, their action, interaction, and balance in relation to health and disease, and the processes of ingestion, absorption, use, and excretion. 13 Inflammation is a stereotypical physiologic response to infections, tissue injury, psychological stress, and other insults. 15, 16 Additional terms listed in Table 1 will be described in more detail within subsequent sections of this article.
ASSESSMENT OF NEURODEVELOPMENT
Behavioral development is driven by changes in brain development, which in turn are driven by the interaction of genes and experience. In this context, it is easy to see how children in low-resource settings (LRS) might be at risk for falling off a typical developmental trajectory, given the large number of early adverse experiences to which many such children are exposed. Such exposures can negatively impact gene expression, which in turn can impact brain development, which in turn can impact behavioral development. Importantly, if such exposures occur during a critical period of brain development, alterations in both brain and behavioral development may be permanent. 12 This interrelationship not only governs the trajectory of a child's development, but is also important in the assessment of child neurodevelopment. Research conducted in LRS focused on the intersection of nutrition and inflammation and their effects on children's development requires attention to the type of research being conducted, its primary purpose, and the methods used.
For the sake of expediency, this article will focus on tests developed for younger children (birth to 3 years of age), for whom there are a paucity of neurodevelopmental assessment tools. However, similar issues discussed in this article
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by guest on June 2, 2017 Downloaded from pertain to tests for school-aged children and adolescents (6-17 years of age), which are more thoroughly reviewed elsewhere. 20 -26 Although child neurodevelopment is described in different domains (eg, cognitive, language, executive function, self-regulation, motor, sensory, emotional, and social), it is important to recognize that these domains are overlapping and mutually influencing and are driven by an integrated brain-behavior circuitry. For children aged <3 years, a comprehensive assessment that includes all domains is the most valuable for assessing concurrent abilities. 20 Results, however, may be poorly predictive of future development. 27, 28 Generally, there has been less emphasis on executive functions, such as socioemotional regulation, impulse control, and the ability to sustain attention, 21 although these areas of neurodevelopment may be affected by different nutritional deficiencies or inflammatory responses. This relationship may be of significance, for example, when considering the effects of malnutrition, because these children are often described clinically as being apathetic with little interaction with others. Measures of executive function in children as young as 2.5 years have moderately strong correlations with intelligence and achievement scores later in childhood 27, 29 and might provide complementary information to the comprehensive developmental assessment. 12 To evaluate neurodevelopment in early childhood, preverbal instruments (eg, behavioral tests, such as elicited imitation or functional electrophysiology like evoked response potentials) allow for assessment during the time period when the brain is most plastic, but also more inaccessible due to child behavior.
Regardless of a child's age, the selection of an instrument should first take into account the specific purpose of the assessment and consideration of which areas of a child's development may possibly be affected. 20 However, the choice of instrument may be complicated by cultural considerations, linguistic variability, caregiver literacy, and the level of training and time commitment required for certain tests as well as their costs and availability. Direct testing of children, for example by using the Bayley Scales of Infant Development, 30 requires extensive training of those administering the test and is time consuming and costly. Moreover, as with many instruments standardized in high-income countries (HIC), some items on the Bayley Scales are not appropriate for children living in some LRS. Conversely, caregiver reports might be subject to biases and affected by the literacy S25 The dynamic interrelationship between environment, genes, and brain whereby the brain develops across time to establish sensory, motor, cognitive, socioemotional, cultural, and behavioral adaptive functions. 12 
Nutrition
The science of food, the nutrients and other substances therein, their action, interaction, and balance in relation to health and disease, and the processes of ingestion, absorption, use, and excretion. 13 
Nutritional status The composition of tissue micro-and macronutrients that refl ect the intake and absorption of a diet, which, if "healthy, " is suffi cient to meet or exceed the needs of the individual, to keep the composition and function within the normal range. 14 
Infl ammation
Stereotypical physiologic response to infections, tissue injury, psychological stress, and other insults. 15 [35] [36] [37] which heretofore have precluded the development of standardized instruments that can be used internationally across cultures. Generally, however, these items speak to differences in access (eg, "climbs up stairs") or cultural differences (eg "drinks from a cup"), and although there may be wide ranges of ages of attainment for some items, the differences between cultures for most items are usually small. 38 
ASSESSMENT OF NUTRITION
Malnutrition has 3 principal constituents: undernutrition (defined by poor growth including underweight, stunting , and wasting), deficiencies in micronutrients, and overweight/obesity. Although nearly all nutrients are important for brain development, some have particularly prominent effects, and their deficiencies confer longterm risks ( Table 2 ). Both fetal and postnatal undergrowth, defined as low weight gain, poor linear growth, or microcephaly reflecting poor brain growth, have been associated with poorer neurodevelopment. 41 -43 Recently, weight overgrowth has also been identified as a risk to the developing brain.
Linear growth is measured as recumbent length in children <2 years of age and thereafter as standing height in comparison with sex-specific population reference growth curves. Currently, the specific effects of inflammation on neurodevelopmental outcomes remain unknown. Inflammation due to infection can affect the brain directly (eg, meningitis, encephalitis, microstrokes due to malaria) with devastating consequences. For example, cerebral malaria affects subsequent frontal lobe function and academic performance. 67 Generalized or central nervous system-specific infections elevate proinflammatory cytokines, which in turn negatively affect neurodevelopment. Cerebral white matter is at high risk during infectious inflammation because oligodendrocytes are sensitive to the proinflammatory cytokines induced by general or brain-specific infections. Based on the trajectory of white matter development, inflammation in fetal life (termed fetal inflammatory response syndrome) and in the first 2 postnatal years would have the greatest effect on white matter. 68 Neurobehavioral consequences of inflammationinduced hypomyelination include poorer connectivity and slower speed of processing.
ASSESSMENT OF INFLAMMATION
Noninfectious processes, such as obesity and psychological stress, also activate many of the same biological processes as infection.
In the absence of protective mechanisms, which include coping strategies and healthy interpersonal relationships, a condition known as toxic stress can result from frequent and prolonged activation of the body's stress response systems, resulting in deleterious effects on children's health and development. 19 There is clear evidence that maternal psychological stress alters fetal/neonatal neurodevelopment. 69 Physiologic responses to stress include activation of the hypothalamicpituitary-adrenocortical axis and sympathetic-adrenomedullary system with resulting increases in stress hormones, such as corticotropin-releasing hormone, cortisol, norepinephrine, and adrenaline, and these changes cooccur with other mediators, including inflammatory cytokines. 19, 70 There is growing evidence from both animal and human studies that persistently elevated levels of stress hormones can alter the size and architecture of the developing brain, specifically the amygdala, hippocampus, and prefrontal cortex. The functional consequences of such changes include increased anxiety and impaired memory and
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by guest on June 2, 2017 Downloaded from mood control and have been related to subsequent problems in the development of linguistic, cognitive, and socioemotional skills. 71 A recent study of holocaust survivors and their offspring also suggests there can be epigenetic alterations from preconceptual severe psychophysiologic trauma. 72 The long-term effects of adverse childhood experiences (ACE) have been best documented in the ACE study, a large, on-going, populationbased study started in 1995 in the United States. 73 The instrument used in this study is a relatively brief questionnaire obtaining information on 10 different categories of adverse experiences. The results have shown a cumulative dose effect with ≥4 adverse experiences correlating to substantial increases in poor health outcomes. Recently, the ACE International Questionnaire has been developed for global use with the support of the WHO. 74 It includes questions on 13 different categories of adverse experiences and is presently undergoing an evaluation, with early evidence of its validity from a study conducted in Nigeria. 75 More research is needed to additionally characterize the direct effects of inflammation on neurodevelopment and, in particular, interventions that can favorably impact this relationship.
Clinically and programmatically relevant biomarkers of inflammation are summarized in Table 4 . Inflammatory biomarkers can be systemic and measured in serum (eg, APPs). Currently, the most frequently measured APPs to assess inflammation are C-reactive protein (CRP) and α1-acid glycoprotein (AGP). CRP rises rapidly and remains elevated for ∼1 week after symptom resolution, whereas AGP rises more slowly but remains elevated for several weeks. 76 Recently, highsensitivity CRP methods have become available, and 5 mg/L has generally become accepted as the upper limit of the normal range. 77 However, lower CRP cutoffs may be useful for detecting acute infection in young children. 78 AGP has been used as a measure of chronic or longer-term exposure to inflammation, but there is some uncertainty as to the threshold that defines "elevated" AGP, especially in relation to the interpretation of nutrition biomarkers. 79 Tissue-specific inflammatory biomarkers can also assess inflammation locally. For example, in addition to direct assessment of small or large intestinal histopathology or special staining of inflammatory cell subtypes or of tight junction disruption, intestinal inflammation as well as intestinal barrier disruption can be measured by using any of a number of fecal and other biomarkers. Examples of these biomarkers include lactulose: mannitol (or rhamnose or xylose) absorption by measuring these sugars in the urine 2 to 5 hours after ingesting a test dose, or by such assessments as fecal α-1-antitrypsin (to indicate barrier disruption enabling this serum protein to "leak" into the gut lumen). Local intestinal inflammatory biomarkers include fecal lactoferrin, calprotectin, myeloperoxidase, neopterin, or lipocalin, any of which might be associated with evidence of systemic inflammation, assessed using biomarkers such as highly-sensitive CRP or AGP. 
THE INTERACTION OF NUTRITION AND INFLAMMATION: CONSIDERATIONS FOR ASSESSMENT
The interactions between inflammation and nutrition are complex and bidirectional. Nutrition can directly impact immune function and the inflammatory response. This topic is reviewed in detail in the INSPIRE report. 7 In summary, malnutrition in all forms impairs both innate and adaptive immunity, which in turn impairs resistance to and recovery from infections. For example, intestinal permeability is increased in severe protein energy malnutrition, which increases the risk of invasive bacterial disease. 82 Vitamin A and zinc deficiency increase the risk of severe infection and result in ∼275 000 child deaths annually, nearly 5% of all child deaths. 83 Although micronutrient supplementation may have beneficial effects on childhood mortality and infectious morbidity (eg, preventive zinc supplementation and reduced incidence of pneumonia and diarrhea), 84 in certain settings, it may also increase the risk of adverse outcomes (eg, iron supplementation and increased malaria morbidity). 85 Conversely, inflammation can negatively affect nutritional status through several mechanisms, including decreased dietary intake, reduced intestinal absorption, and increased urinary excretion. 86 Additionally, inflammation can directly affect concentrations of nutrients, because some nutrition biomarkers are themselves APPs (eg, serum ferritin and retinol). For example, ferritin is a positive APP and therefore increases in subclinically-infected/inflamed individuals irrespective of iron status. 87 Thus, without taking into account the effects of inflammation on ferritin, the prevalence of low iron stores can be underestimated by 14%. 88 Although high ferritin in noninflamed individuals would suggest iron overload, in settings with inflammation, total body iron is likely normal or low. The anemia is not due to total body iron deficiency, but to functional iron deficiency. Overall, it can be difficult S30 by guest on June 2, 2017 Downloaded from to impossible to interpret total body iron status, much less brain iron status, under these conditions. The Centers for Disease Control and Prevention and WHO recommend measuring inflammatory markers for the assessment of population iron status by using serum ferritin, and to either exclude individuals from analysis who are inflamed, or to raise the cutoff of ferritin to define deficiency. 89, 90 However, there are no universally accepted methods for accounting for inflammation in estimating micronutrient status, which can lead to incorrect diagnosis of individuals, as well as over-or underestimation of the prevalence of deficiency in a population. 7, 47, 87, 91 To address these challenges in the assessment of nutrition status, a collaborative research group called Biomarkers Reflecting Inflammation and Nutrition Determinants of Anemia has been formed to pool and analyze data from populationbased nutrition surveys and answer priority research questions related to the assessment of micronutrient status in settings of inflammation. 79 Preliminary findings suggest a strong relationship between CRP and AGP and both iron (ferritin, soluble transferrin receptor) and vitamin A (retinol binding protein) biomarkers. A recommended statistical approach to account for the confounding effects of inflammation on these nutrient biomarkers is being developed.
There is a tendency to address nutrient deficiencies as "supplyside" problems, which leads logically to an intervention of giving more of the nutrient in question. Although this may be appropriate in most cases, it is important to recognize that nonnutritional factors influence nutrient status, nutrient biomarker readouts, or both. In the catabolic state of severe infection, macronutrient trafficking and the hormonal milieu in which nutrients operate are likely altered. Counterregulatory hormones, such as cortisol, promote tissue breakdown (eg, glycogen, muscle mass) to provide a ready source of glucose. Relative insulin, insulinlike growth factor 1, and growth hormone resistance ensure that macronutrients are not used for tissue accretion (eg, growth). The subsequent growth slowing with prolonged illness ultimately will affect macronutritional biomarkers, a High-sensitivity CRP may show minor, but potentially important, elevations in the 15-to 30-mg/L range that may be seen with common milder infections, in contrast to the higher levels (>300 mg/L) seen only with major infections or infl ammatory processes.
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RESEARCH GAPS AND FRONTIERS
Despite advances in the understanding of the relationships and influence of nutrition and inflammation on child neurodevelopment, important research gaps remain. We summarize key gaps in knowledge related to the assessment of neurodevelopment, nutrition, and inflammation in Table  5 and include studies needed to address these research questions.
A significant gap in the current science of child neurodevelopmental assessment pertains to the lack of valid and sensitive tests of brain/ behavior development in young, preverbal children with good predictive validity. Furthermore, the timing of when to assess neurodevelopment may be influenced by the domain of interest and even the child's sex. 92 Understanding whether early assessment predicts later-life functioning is particularly a challenge because neurodevelopment itself is so dynamic. Measures of cognitive and motor development in infants that are sensitive to gestational and perinatal risk factors, and at the same time are predictive for developmental delay and disability later in childhood, are urgently needed. Experimental measures of infant development, such as gaze length for violation of expectancy for physical events 93 -95 and neuromotor proficiency in movement and balance, 96 might be good candidate measures for such an infant neuropsychological assessment battery.
An additional significant gap pertains to the development of measures from infancy through middle childhood into adolescence that evaluate the modifying impact of biological and environmental risk and resilience in a consistent and reciprocal manner. Sensitive biomarkers of risk that relate to early child development measures have been documented and additional studies are underway. 97 -99 However, the notion of resilience to developmental risk is not well defined or measured for children in LRS. 100 Positive neuroplasticity within the developing brains of children is a double-edged sword, with risk and resilience cutting both ways in the face of genetics and environment. 101 What is needed is a comprehensive model to encompass the genetic, biological, neuropsychological, and social factors of resilience that can be engineered to buffer children against all manner of risk to normal brain/behavior development. 102 Furthermore, we need to understand the predominant forms of child development risk and resilience factors as children develop across the life span from gestation (in utero) through adolescence.
A final gap in child neurodevelopmental testing pertains to its integration with cutting-edge tools that provide a more direct assessment of the brain, bypassing behavior. Such tools possess several advantages. First, because they often do not require a verbal or motor response, they may be more "culturefree" than many behavioral assays used in LRS (particularly those exported from high-resource western settings). Second, particularly in the infancy period, they may permit an evaluation of brain function during a time when the behavioral repertoire is limited. Finally, such tools may shed light on the neural mechanisms that underpin behavior, something behavioral tools cannot do. One such example is a recent seminal publication that used magnetoencephalography brain imaging technology to provide the first evidence of the use of computerized cognitive game training to strengthen the intra-and interhemispheric brain pathways undergirding attention and working memory processes activated by these games. 103 Another example of the potential for the integration of new technologies to child development assessment is that of near-infrared spectroscopy. This technology is a relatively new optical imaging technique that has shown promise in examining child neurodevelopment and therefore potentially has a role in examining the interactions of nutrition, inflammation, and child neurodevelopment. Compared with other neuroimaging techniques, near-infrared spectroscopy has the advantage of being noninvasive, portable, quiet, relatively low-cost, and less sensitive to motion artifacts. 104 Finally, electrophysiological tools, such as the EEG and event-related potentials, have been used for decades to examine the temporal and spatial neural mechanisms underlying a variety of perceptual and cognitive skills. 105 -107 The application of these technologies to studies on the effects of nutrition and inflammation on child neurodevelopment in LRS will of necessity depend on the ability to implement and fund the technology.
With the advent of new tools to assess the full effects of specific diets, environments, and microorganisms (including potential pathogens and enteric or other infections) on the metabolism and microbiota of the child, research opportunities emerge to dissect relevant inflammatory and nutritional pathways and develop innovative interventions to optimize neurodevelopment. This work must address the nutrition and inflammation assessment questions listed in Table 5 , as well as the need to integrate our understanding of these assessments with full metabolomic studies and long-term follow-up of neurodevelopment in the field. For this work to occur, innovative biomarkers and relevant animal models are needed in which outcomes can parallel more complex nutritional and microbial realities Properly powered longitudinal studies of normal concentrations of nutrients (particularly those that have the greatest impact on early brain development), starting with cord blood and tracking through 1 y of age. 7. Lack of defi ned relationships between cutoff values for specifi c nutrients and acute brain function (behavior) at specifi c ages.
Measurement of biologically plausible acute brain/behavior functioning as a function of nutrient biomarker status. 8. Lack of defi ned relationships between cutoff values for specifi c nutrients at a given age and long-term brain function (behavior).
Measurement of biologically plausible long-term brain/behavior functioning as a function of nutrient biomarker status in childhood. 9. Need to demonstrate that (1) nutrient biomarkers respond to nutrient interventions and that (2) response of nutrient biomarkers index concurrent changes in brain/behavior status.
Clinical trials
10. Need to identify nutrient driven alterations in brain function that are measureable. The ideal assessment would be specifi c to the nutrient/metabolite (eg, "signature effect" of iron defi ciency). These may vary for a given nutrient by age of the subject.
Discover/develop new biomarkers that are "read outs" of metabolic processes occurring in the brain. This may well use proteomic or metabolomic approaches rather than relying on standard biomarkers that index the nutrient's status. These protein or metabolism changes would refl ect brain metabolic alterations induced by the nutrient's metabolic properties. 11. What is the magnitude and duration of the effects of infl ammation on nutritional status and nutritional biomarkers? How long after the infl ammatory event before the biomarkers become useful indices of nutrition?
Longitudinal studies in children that defi ne which and when commonly used nutritional biomarkers are affected by infl ammation, including infectious and noninfectious triggers of infl ammation. 12. Is there evidence that type of feeding (eg, own mother's milk versus formula in newborns, grain-based versus not, fi sh consumption, etc) is associated with neurodevelopment? Assessment of infl ammation 13. Need improved measures assessing low amounts of local or systemic acute endotoxin (eg, lipopolysaccharide) exposure. 14. What is the role of maternal infl ammation on the development of the fetus? 15 
